Cellectar Biosciences is a biotechnology business based in the US. Cellectar Biosciences shares (CLRB) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $3.29 – an increase of 8.22% over the previous week. Cellectar Biosciences employs 11 staff and has a market cap (total outstanding shares value) of 0.00.
Become a Finder member, open a SoFi Active Invest account and make a first deposit of $1,000 or more to receive a $150 gift card. Offer ends March 4, 2026.
T&Cs and limits apply.
0588148b-2286-4b8f-9672-9c8cdafc0370-Get up to $1,000 in stock
Get up to $1,000 in stock
Trade stocks, options, ETFs, mutual funds, alternative asset funds
$0 commission on stocks, ETFs and options with no options contract fees
Get up to $1,000 in stock when you open & fund a new Active Invest account.
Probability of Member receiving $1,000 is a probability of 0.026%; If you don’t make a selection in 45 days, you’ll no longerqualify for the promo. Customer must fund their account with a minimum of $50.00 to qualify. Probability percentage is subject to decrease.
Terms and conditions apply*. For 401k rollovers, existing SoFi IRA members must complete 401k rollovers via this link See full terms and For SoFi members without a SoFi IRA, a SoFi IRA must first be opened, and 401k rollover must be completed utilizing Capitalize via this link. SoFi and Capitalize will charge no additional fees to process a 401(k) rollover to a SoFi IRA. SoFi is not liable for any costs incurred from the existing 401k provider for rollover. Please check with your 401k provider for any fees or costs associated with the rollover. For IRA contributions, only deposits made via ACH and cash transfer from SoFi Bank accounts are eligible for the match. Click here for the 1% Match terms and conditions.
Must be a SoFi Plus member at the time a recurring deposit is received into your SoFi Active or Automated investing account to qualify. Bonus calculated on net monthly recurring deposits made via ACH and paid out as Rewards Points. See Rewards Terms of Service. SoFi reserves the right to change or terminate this promotion at any time without notice. See terms and limitations. https://www.sofi.com/sofiplus/invest/#disclaimers
eToro securities trading offered by eToro USA Securities, Inc. (‘the BD”), member of FINRA and SIPC. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. Finder is not an affiliate and may be compensated if you access certain products or services offered by the BD.
d19c0be9-29b6-4644-a071-32c476ff5e24-Top pick for match bonus
Top pick for match bonus
Trade stocks, ETFs, options, futures and bonds all in one place
$0 commissions on stocks, ETFs and equity options, with low contract fees
Deposit or transfer $100,000+ to earn a 4% Match Bonus. Plus: Get a $100 transfer fee reimbursement on your first brokerage transfer of $2,000 or more. T&C apply.
Open an account.Provide your personal information and sign up.
Fund your account.Deposit funds into your account by linking your banking information or transfer funds from another trading account.
Search for the stock name – CLRB.Search for the stock by name or ticker symbol.
Buy the stock. Place your order. It's that simple.
Buy Cellectar Biosciences stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Cellectar Biosciences stock price (NASDAQ: CLRB)
Use our graph to track the performance of CLRB stocks over time.
Is it a good time to buy Cellectar Biosciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Cellectar Biosciences price performance over time
Historical closes compared with the close of $3.29 from 2026-02-13
1 week (2026-02-06)
8.22%
1 month (2026-01-15)
-9.86%
3 months (2025-11-14)
13.45%
6 months (2025-08-15)
-24.19%
1 year (2025-02-14)
1,031.36%
2 years (2024-02-15)
-8.36%
3 years (2023-02-15)
97.44%
5 years (2021-02-12)
750
Cellectar Biosciences financials
Gross profit TTM
$0
Return on assets TTM
-72.31%
Return on equity TTM
-145.42%
Profit margin
0%
Book value
$2.34
Market Capitalization
$12.9 million
TTM: trailing 12 months
Cellectar Biosciences share dividends
We're not expecting Cellectar Biosciences to pay a dividend over the next 12 months.
Have Cellectar Biosciences's shares ever split?
Cellectar Biosciences's shares were
split on a 1:30 basis on 23 June 2025
. So if you had owned 30 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Cellectar Biosciences shares – just the quantity. However, indirectly, the new 2900% higher share price could have impacted the market appetite for Cellectar Biosciences shares which in turn could have impacted Cellectar Biosciences's share price.
Cellectar Biosciences share price volatility
Over the last 12 months, Cellectar Biosciences's shares have ranged in value from as little as $2.45 up to $20.595. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cellectar Biosciences's is 0.314. This would suggest that Cellectar Biosciences's shares are less volatile than average (for this exchange).
Cellectar Biosciences overview
Cellectar Biosciences, Inc. , a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer in the United States. The company's lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study for patients with B-cell malignancies; Phase 2a clinical study for patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia cohort, r/r multiple myeloma (MM) cohort, and r/r non-Hodgkin's lymphoma cohort; Phase 1 clinical study for r/r pediatric patients with select solid tumors, lymphomas, and malignant brain tumors; and Phase 1 clinical study for r/r head and neck cancer. It also develops CLR 1900, a PDC chemotherapeutic program that is in the preclinical development stage to treat solid tumors. It has collaborative with Orano Med to develop CLR 12120 Series; and LegoChem Bio. Cellectar Biosciences, Inc. was founded in 2002 and is headquartered in Florham Park, New Jersey.
Frequently asked questions
null What percentage of Cellectar Biosciences is owned by insiders or institutions? Currently 3.911% of Cellectar Biosciences shares are held by insiders and 8.03% by institutions.How many people work for Cellectar Biosciences? Latest data suggests 11 work at Cellectar Biosciences.When does the fiscal year end for Cellectar Biosciences? Cellectar Biosciences's fiscal year ends in December.Where is Cellectar Biosciences based? Cellectar Biosciences's address is: 100 Campus Drive, Florham Park, NJ, United States, 07932What is Cellectar Biosciences's ISIN number? Cellectar Biosciences's international securities identification number is: US15117F8077What is Cellectar Biosciences's CUSIP number? Cellectar Biosciences's Committee on Uniform Securities Identification Procedures number is: 67000M100
Discover the best stock picking services based on expert analysis, pricing, and strategy fit. Compare top tools to find the right service for your investing style in 2026.
Discover the best robo-advisors of 2026. Compare fees, account minimums and features from top platforms that automate investing for beginners and pros.
What you need to know about investing in the leading indicator for the overall US stock market.
Advertiser disclosure
Finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which Finder receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. Finder compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
How likely would you be to recommend Finder to a friend or colleague?
0
1
2
3
4
5
6
7
8
9
10
Very UnlikelyExtremely Likely
Required
Thank you for your feedback.
Our goal is to create the best possible product, and your thoughts, ideas and suggestions play a major role in helping us identify opportunities to improve.
